CL2021001458A1 - 3ß-(benciloxi)-17a-metil-pregn-5-en-20-ona para uso en el tratamiento de trastornos cognitivos. - Google Patents
3ß-(benciloxi)-17a-metil-pregn-5-en-20-ona para uso en el tratamiento de trastornos cognitivos.Info
- Publication number
- CL2021001458A1 CL2021001458A1 CL2021001458A CL2021001458A CL2021001458A1 CL 2021001458 A1 CL2021001458 A1 CL 2021001458A1 CL 2021001458 A CL2021001458 A CL 2021001458A CL 2021001458 A CL2021001458 A CL 2021001458A CL 2021001458 A1 CL2021001458 A1 CL 2021001458A1
- Authority
- CL
- Chile
- Prior art keywords
- treatment
- cognitive disorders
- pregn
- benzyloxy
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/009—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by only one oxygen atom doubly bound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se relaciona de manera general con un derivado específico de pregnenolona para su uso en el tratamiento de trastornos cognitivos. Más particularmente, la invención se relaciona con un compuesto de la Fórmula (I) Fórmula (I) para su uso en el tratamiento de trastornos cognitivos. Efectivamente, el compuesto de la invención es muy potente in vivo en la corrección de deterioros cognitivos observados en trastornos cognitivos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18306716.4A EP3669876A1 (en) | 2018-12-18 | 2018-12-18 | 3béta-(benzyloxy)-17alpha-methyl-pregn-5-en-20-one for use in the treatment of cognitive disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2021001458A1 true CL2021001458A1 (es) | 2022-01-21 |
Family
ID=65278139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2021001458A CL2021001458A1 (es) | 2018-12-18 | 2021-06-03 | 3ß-(benciloxi)-17a-metil-pregn-5-en-20-ona para uso en el tratamiento de trastornos cognitivos. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20220017562A1 (es) |
EP (2) | EP3669876A1 (es) |
KR (1) | KR20210124962A (es) |
CN (1) | CN113260366B (es) |
AU (1) | AU2019409912A1 (es) |
BR (1) | BR112021011654A2 (es) |
CA (1) | CA3118210C (es) |
CL (1) | CL2021001458A1 (es) |
IL (1) | IL284032A (es) |
MA (1) | MA54518A (es) |
MX (1) | MX2021006904A (es) |
WO (1) | WO2020127468A1 (es) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA05011670A (es) * | 2003-05-01 | 2005-12-15 | Vernalis Res Ltd | Derivados de azetidincarboxamida y su uso en el tratamiento de trastornos mediados por el receptor cb1. |
CA2657640A1 (en) * | 2006-07-14 | 2008-01-24 | Pfizer Products Inc. | Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2-methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine |
JP2014515361A (ja) | 2011-05-20 | 2014-06-30 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Cb1受容体のアンタゴニスト |
CA2892347C (en) * | 2012-11-28 | 2019-04-02 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | 3-(4'-substituted)-benzyl-ether derivatives of pregnenolone |
SI2976074T1 (sl) * | 2013-03-19 | 2020-07-31 | Universitat Pompeu-Fabra Unitat d-Innovacio i Parcs de Recerca | Antagonisti kanabionidnega receptorja cb1 za uporabo pri tretiranju bolezni v povezavi z nevronskimi dendritičnimi anomalijami |
-
2018
- 2018-12-18 EP EP18306716.4A patent/EP3669876A1/en not_active Withdrawn
-
2019
- 2019-12-18 WO PCT/EP2019/085927 patent/WO2020127468A1/en unknown
- 2019-12-18 EP EP19831675.4A patent/EP3897655A1/en active Pending
- 2019-12-18 US US17/414,826 patent/US20220017562A1/en active Pending
- 2019-12-18 AU AU2019409912A patent/AU2019409912A1/en active Pending
- 2019-12-18 KR KR1020217019491A patent/KR20210124962A/ko unknown
- 2019-12-18 BR BR112021011654-0A patent/BR112021011654A2/pt unknown
- 2019-12-18 MA MA054518A patent/MA54518A/fr unknown
- 2019-12-18 MX MX2021006904A patent/MX2021006904A/es unknown
- 2019-12-18 CN CN201980081303.1A patent/CN113260366B/zh active Active
- 2019-12-18 CA CA3118210A patent/CA3118210C/en active Active
-
2021
- 2021-06-03 CL CL2021001458A patent/CL2021001458A1/es unknown
- 2021-06-15 IL IL284032A patent/IL284032A/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20210124962A (ko) | 2021-10-15 |
AU2019409912A1 (en) | 2021-05-27 |
EP3897655A1 (en) | 2021-10-27 |
CA3118210A1 (en) | 2020-06-25 |
IL284032A (en) | 2021-08-31 |
WO2020127468A1 (en) | 2020-06-25 |
MX2021006904A (es) | 2021-09-30 |
US20220017562A1 (en) | 2022-01-20 |
EP3669876A1 (en) | 2020-06-24 |
JP2022515373A (ja) | 2022-02-18 |
CN113260366A (zh) | 2021-08-13 |
MA54518A (fr) | 2022-02-16 |
BR112021011654A2 (pt) | 2021-09-08 |
AU2019409912A8 (en) | 2021-06-17 |
CA3118210C (en) | 2024-05-21 |
CN113260366B (zh) | 2024-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY37537A (es) | Derivados de pirazol como inhibidores malt1 | |
UY37124A (es) | Nuevos compuestos de 6,7-dihidro-5h-benzo[7]anuleno sustituidos, procesos para su preparación y usos terapéuticos de los mismos | |
MX2023001876A (es) | Derivados de rapamicina. | |
MX2020004917A (es) | Procesos para la resolucion de los derivados de la benzodiazepina-2-ona y de la benzoazepin-2-ona. | |
MX2021008002A (es) | Sales nuevas y forma polimorfica del acido bempedoico. | |
UY35572A (es) | Nuevos agonistas del receptor de somatostatina subtipo 4 (sstr4) | |
AR116790A1 (es) | PROCEDIMIENTO PARA LA PREPARACIÓN DE 3a-HIDROXI-5a-PREGNAN-20-ONA (BREXANOLONA) | |
EA201791802A1 (ru) | СШИТЫЕ ДИГИДРО-4H-ПИРАЗОЛО[5,1-c][1,4]ОКСАЗИНИЛОВЫЕ СОЕДИНЕНИЯ И АНАЛОГИ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ЦНС | |
MX2019003724A (es) | Oxisteroles sustituidos en c7 y metodos de uso de los mismos. | |
EA201590381A1 (ru) | Замещенные пиразолы, используемые в качестве блокаторов кальциевых каналов n-типа | |
UY37774A (es) | Compuestos 5-cianoindol sustituidos y usos de los mismos | |
EA201790800A1 (ru) | Замещенные производные бензотиофенила в качестве агонистов gpr40 для лечения диабета ii типа | |
ECSP10010192A (es) | 5-[(3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-onas, un proceso para su producción y su uso como agentes antiinflamatorios | |
CL2021000844A1 (es) | Compuestos de indolinona para uso como inhibidores de map4k1 | |
PH12019502093A1 (en) | Novel ester compounds, method for the production thereof and use thereof | |
PH12017501422A1 (en) | 1-heterocyclyl isochromanyl compounds and analogs for treating cns disorders | |
CL2017003133A1 (es) | Uso de derivados de bencimidazol para escape ácido nocturno | |
CO2020001471A2 (es) | Compuesto pentacíclico | |
CL2020001047A1 (es) | Derivados de imidazol condensado sustituidos por grupos de hidroxia terciaria como inhibidores pi3k-gamma. | |
EA202190272A1 (ru) | Дополнительно замещенные производные триазолохиноксалина | |
EA202190271A1 (ru) | Замещенные триазолохиноксалиновые производные | |
CL2022002589A1 (es) | Tratamiento de trastornos respiratorios | |
CO2020003424A2 (es) | Cristal | |
BR112018070345A2 (pt) | processo para a preparação de derivados de 4-aminoindano e amidas de aminoindano relacionadas | |
CU20190035A7 (es) | Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina |